标题
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 7, Pages 3268-3279
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2015-12-03
DOI
10.1074/jbc.m115.702076
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia
- (2014) D. Sasca et al. BLOOD
- Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
- (2014) Jia-Xing Wang et al. BMC CANCER
- SIRT3 is a novel prognostic biomarker for esophageal squamous cell carcinoma
- (2014) Shu-Mei Yan et al. MEDICAL ONCOLOGY
- Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation
- (2012) Yuan-Yuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance
- (2012) Michaël Van Damme et al. Epigenetics
- Sirtuin Catalysis and Regulation
- (2012) Jessica L. Feldman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status
- (2012) Wei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calorie Restriction and SIRT3 Trigger Global Reprogramming of the Mitochondrial Protein Acetylome
- (2012) Alexander S. Hebert et al. MOLECULAR CELL
- Histone Deacetylase in Chronic Lymphocytic Leukemia
- (2012) J.C. Wang et al. ONCOLOGY
- SIRT3 and cancer: Tumor promoter or suppressor?
- (2011) Turki Y. Alhazzazi et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Mitochondrial membrane potential probes and the proton gradient: a practical usage guide
- (2011) Seth W. Perry et al. BIOTECHNIQUES
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
- (2011) Lydia W.S. Finley et al. CANCER CELL
- Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS
- (2011) Yaohui Chen et al. EMBO REPORTS
- Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic ‘sensor/effector’ compounds
- (2011) Nils Lilienthal et al. LEUKEMIA & LYMPHOMA
- SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
- (2011) E L Bell et al. ONCOGENE
- Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer
- (2010) Turki Y. Alhazzazi et al. CANCER
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
- (2010) Hyun-Seok Kim et al. CANCER CELL
- Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction
- (2010) Shinichi Someya et al. CELL
- Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 Activation
- (2010) Xiaolei Qiu et al. Cell Metabolism
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to Stress
- (2010) Randa Tao et al. MOLECULAR CELL
- Hydrolase Regulates NAD+Metabolites and Modulates Cellular Redox
- (2009) Lei Tong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substrates and Regulation Mechanisms for the Human Mitochondrial Sirtuins Sirt3 and Sirt5
- (2008) Christine Schlicker et al. JOURNAL OF MOLECULAR BIOLOGY
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started